Clinical trials
Observational Aortic Aneurysm, Abdominal trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 3 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Unknown status | 9 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University College, London | 5 |
| Vascutek Ltd. | 4 |
| Imperial College London | 3 |
| Medtronic Cardiovascular | 3 |
| University of Edinburgh | 3 |
| University of Leicester | 3 |
| Liverpool University Hospitals NHS Foundation Trust | 2 |
| TriVascular, Inc. | 2 |
| Amsterdam UMC, location VUmc | 1 |
| Bolton Medical | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aortic Aneurysm, Abdominal | 35 |
| Peripheral Arterial Disease | 6 |
| Angina, Stable | 5 |
| Angina, Unstable | 5 |
| Heart Failure | 5 |
| Ischemic Stroke | 5 |
| Death, Sudden, Cardiac | 4 |
| Heart Arrest | 4 |
| Ischemic Attack, Transient | 4 |
| Stroke | 4 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.